Drug Topics

OCTOBER 10, 2024

Researchers analyzed the potential role of nonphysician health care providers to provide vaccine services outside of traditional health care settings.

Vaccines 185

Vaccines 185

STAT

OCTOBER 10, 2024

The director general of the Africa Centres for Disease Control and Prevention and Rwanda’s health minister on Thursday criticized the U.S. government’s decision to urge Americans to avoid travel to Rwanda because of the country’s ongoing Marburg outbreak. Calling the travel alert a travel ban — it is not — Jean Kaseya, who heads the Africa CDC, suggested the U.S. action was counterproductive and unfair to a country that is being transparent about its efforts to

134

134

Fierce Healthcare

OCTOBER 10, 2024

Intravenous fluid shortages appear to be affecting the majority of the nation’s healthcare providers, who as a result are already beginning to cancel procedures, survey data published Thursday show | Premier said 86% of its provider members are reporting shortages, and more than half have less than 10 days supply on hand. Respondents also said they were beginning or considering procedure cancellations, and have begun receiving solicitations from "unapproved, gray market suppliers.

130

130

STAT

OCTOBER 10, 2024

Telehealth providers treating opioid use disorder, ADHD, and women’s health issues say the sector is in a state of frustration and chaos as the pandemic-era flexibilities that allowed their businesses to thrive are set to end with no new rules in sight. With just months to go before the ability to prescribe controlled substances online dramatically changes overnight, the vacuum of information is forcing them to devote significant energy preparing for the unknown.

Controlled Substances 134

Controlled Substances Patient Care 134

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Fierce Healthcare

OCTOBER 10, 2024

Just 40% of Medicare Advantage prescription drug plans offered in 2025 achieved a score of four stars or higher, the Centers for Medicare & Medicaid Services (CMS) revealed Oct. 10. | It's harder than ever for Medicare Advantage plans to score well on star ratings. Here's how they performed for 2025.

122

122

STAT

OCTOBER 10, 2024

Nearly 60% of the experts who reviewed manuscripts for four prominent medical journals received at least one payment from industry during a recent three-year period and, overall, these reviewers or their institutions received more than $1 billion from companies, according to a new analysis. Between 2020 and 2022, 1,155 of the 1,962 experts who reviewed studies for The BMJ, JAMA, The Lancet, and The New England Journal of Medicine received some form of payment.

132

132

STAT

OCTOBER 10, 2024

Amid excitement over everything from Chat-GPT to Nobel Prize-winning chemistry research that uses artificial intelligence to predict protein structures, academics Aravind Narayan and Sayash Kapoor have established a reputation for throwing cold water on at least some of the claims about how AI will transform people’s lives.  Narayan, a professor of computer science at Princeton University, went viral in 2019 for a talk he gave at MIT on how to recognize overblown declarations about A

Hospitals 130

Hospitals 130

Fierce Pharma

OCTOBER 10, 2024

Activist investor Starboard accuses Pfizer of strong-arming former execs into backing CEO Bourla ahead of strategy meeting zbecker Thu, 10/10/2024 - 11:03

116

116

STAT

OCTOBER 10, 2024

Bill Nye the Science Guy is temporarily rebranding. For now, he’s “ Bill Nye the Ataxia Advocate Guy ,” as he aims to bring awareness to a neurological disease that has affected his family for generations. Nye has previously spoken about the genetic disease, which makes it difficult for people with the condition to control their muscles and often leads to problems with walking and speech, in a documentary released in 2017.

127

127

The Checkup by Singlecare

OCTOBER 10, 2024

Capsaicin is a natural compound found in capsicum, or peppers. It’s responsible for giving jalapeños, cayenne peppers, and other hot peppers their signature heat. For many years, capsaicin has been extracted from peppers and used as a natural remedy for pain , according to the National Institutes of Health (NIH). Capsaicin in chili peppers is also known to have antioxidant effects , which help protect against disease. “ Capsaicin has been recognized for its numerous health benefits, including pr

Compounding 104

Compounding Dosage FDA 104

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

STAT

OCTOBER 10, 2024

This story was first published in the online edition of Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up  here  to get it delivered to their inbox. Sarepta Therapeutics CEO Doug Ingram is upset about the company’s slumping stock price.  Investors who have interacted with him this summer, including during a whitewater rafting trip, told me Ingram has been venting his frustration to anyone who will listen.

122

122

pharmaphorum

OCTOBER 10, 2024

Media personality Nadia Sawalha is heading a fundraising effort to launch an appeal against NICE's recent rejection of a breast cancer therapy Enhertu.

110

110

STAT

OCTOBER 10, 2024

In the largest settlement of its kind, Teva Pharmaceuticals agreed to pay $425 million to resolve allegations the company and a related business paid kickbacks to charitable foundations in order to boost usage of a pricey medicine. Separately, the drugmaker agreed to pay $25 million to settle charges of participating in a price-fixing scheme with other generic companies.

Pharmaceutical Companies 118

Pharmaceutical Companies Pharmaceutical Companies 118

Pharmacy Times

OCTOBER 10, 2024

The FDA also approved the FoundationOne Liquid CDx assay as a companion diagnostic device to identify patients who would benefit from the treatment.

FDA 114

FDA 114

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

STAT

OCTOBER 10, 2024

Over the past decade, there has been a clear and unprecedented exodus of young life scientists from academia and into lucrative industry jobs. But new data provide evidence that this trend is slowing, at least for now. The latest numbers from the Survey of Earned Doctorates, an annual National Science Foundation census of freshly minted Ph.D. graduates, show that 61.6% of biomedical scientists who had a job lined up were bound for industry in 2023.

112

112

pharmaphorum

OCTOBER 10, 2024

Ono Pharma and Boehringer Ingelheim both added to their cancer pipelines, licensing drugs from LigaChem Bio and Circle Pharma, respectively.Ono's deal with South Korean antibody-drug conjugate (ADC) specialist LigaChem is worth up to $700 million and covers a license to a preclinical-stage candidate for solid tumours, as well as an R&D collaboration to seek out other ADC candidates.

100

100

STAT

OCTOBER 10, 2024

How does John Maraganore decide which startups to get involved in? Why are longevity-minded tech bros getting involved with a controversial CRISPR scientist? And who would you rather hang out with at the STAT Summit next week, Adam or Allison? We discuss all that and more on this week’s episode of “The Readout LOUD,” STAT’s biotech podcast.

111

111

European Pharmaceutical Review

OCTOBER 10, 2024

A draft joint EU network strategy to 2028 has been published by the European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA). This is updated strategy replaces the original five-year strategy, which was developed to cover from 2021 to 2025 (EMANS 2025). Revised strategy – adapting to change The draft strategy covers the following focus areas up to 2028: Accessibility to support pathways for medicine access in the EU Leveraging data, digitalisation and artificial intelligen

98

98

STAT

OCTOBER 10, 2024

On Thursday, the CDC released new data showing that almost 15.5 million U.S. adults are living with ADHD. More than half of those individuals received their diagnosis in adulthood.   That includes me. The diagnosis came as a relief and validation — a way to understand years of impulsivity, inattention, and struggles with daily life. I was diagnosed at age 36, after first one, then two, and ultimately, four of my five children were also diagnosed with ADHD.

111

111

Outsourcing Pharma

OCTOBER 10, 2024

The big pharma company AstraZeneca has forged a licensing pact worth $2 billion with the Chinese firm CSPC Pharmaceutical Group for access to an experimental small molecule treatment for dyslipidemia.

98

98

STAT

OCTOBER 10, 2024

This story first appeared in The Readout newsletter.  Sign up for The Readout  and receive STAT’s award-winning biotech news delivered straight to your inbox.  Morning. Today, we are sad to report that more children have developed blood cancers after receiving Bluebird Bio’s CALD gene therapy, Skysona. There’s a new twist in the Pfizer activist shareholder campaign.

111

111

Drug Topics

OCTOBER 10, 2024

Guselkumab is currently approved by the FDA to treat adults with moderate to severe plaque psoriasis, adults with active psoriatic arthritis, and adults with moderately to severely active ulcerative colitis.

FDA 86

FDA 86

STAT

OCTOBER 10, 2024

U.S. Sen. Elizabeth Warren has asked the Federal Trade Commission “closely scrutinize” a $16.5 billion deal in which Novo Nordisk’s parent foundation would acquire Catalent, a leading contract drug manufacturer, over concerns the acquisition would give the pharmaceutical company an unfair advantage in the burgeoning market for drugs used to treat obesity and diabetes.

Packaging 109

Packaging Pharmaceutical Companies Pharmaceutical Companies 109

Drug Topics

OCTOBER 10, 2024

This year’s annual meeting of the American College of Chest Physicians featured more than 300 educational sessions, insights from over 600 faculty members, and 29.5 hours of CE credits.

112

112

STAT

OCTOBER 10, 2024

The ink had scarcely dried on  new federal rules  for enforcement of the Mental Health Parity and Addiction Equity Act of 2008 when U.S. health plans  threatened potential legal action  to block them.  Buoyed by a recent Supreme Court ruling that  shifts power away from federal agencies , health plans apparently hope to keep the departments of Labor, Treasury, and Health and Human Services from making parity a reality, years after Congress passed the law with r

94

94

pharmaphorum

OCTOBER 10, 2024

Starboard Value alleges former Pfizer execs Ian Read and Frank D'Amelio were bullied into lending their support to current management

111

111

STAT

OCTOBER 10, 2024

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds.  Sign up here. We’ve got a hurricane-centric newsletter for you this morning. I am writing this hours before Milton makes landfall — stay safe, everyone.

Hospitals 101

Hospitals 101

Fierce Pharma

OCTOBER 10, 2024

As Novo Holdings hopes to close its $16.5 billion acquisition of CDMO Catalent by the end of the year, the deal is facing a fresh round of lawmaker scrutiny. | In a letter to the chair of the U.S. Federal Trade Commission, Lina Khan, Sen. Elizabeth Warren is calling on the antitrust agency to “carefully scrutinize” Novo Holding’s multibillion-dollar bid for CDMO Catalent.

94

94

STAT

OCTOBER 10, 2024

Top of the morning to you and a fine one it is. Blue skies, cool breezes, and plenty of chirping birds are enveloping the comfy Pharmalot campus, which is cause to fire up the coffee kettle for yet another cup of stimulation. Our choice today is strawberry creme — sweets for the sweet, you know. Meanwhile, we have assembled the latest menu of tidbits for you to peruse.

Compounding 100

Compounding 100

Pharmacy Times

OCTOBER 10, 2024

Knowing the benefits and effects of norgestrel can assist pharmacists when counseling patients.

123

123

STAT

OCTOBER 10, 2024

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences.  Sign up to get it  delivered in your inbox every Tuesday and Thursday. Lilly appoints Chief AI Officer Drug giant Eli Lilly announced Thomas Fuchs as its first chief AI officer. Previously, Fuchs was director of the Hasso Plattner Institute for Digital Health at Mount Sinai in New York where he helped lead work on computational pathology.

100

100

Fierce Pharma

OCTOBER 10, 2024

In prostate cancer, Pfizer’s Talzenna already holds the broadest FDA approval within the PARP inhibitor class. | In prostate cancer, Pfizer’s Talzenna already holds the broadest FDA approval within the PARP inhibitor class. Now, with new data indicating the drug could prolong patients’ lives, the company is targeting an even wider label.

Labelling 91

Labelling FDA 91

Pharmacy Times

OCTOBER 10, 2024

Although the findings indicate a potential for predicting asthma or wheezing onset, these trends cannot yet be used for early diagnoses in individual children.

94

94

Drug Topics

OCTOBER 10, 2024

Additional research is needed to determine if the therapy can help with cognitive symptoms of post–COVID-19 condition.

94

94